CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

Jian Zhang, Lalit Patel, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

CCL2 is a chemokine known to recruit monocytes and macrophages to sites of inflammation. A growing body of research suggests CCL2 is progressively overexpressed in tumor beds and may play a role in the clinical progression of solid tumors. Cancer cells derived from several solid tumor types demonstrate functional receptors for CCL2, suggesting this chemokine may achieve tumorigenicity through direct effects on malignant cells; however, a variety of normal host cells that co-exist with cancer in the tumor microenvironment also respond to CCL2. These cells include macrophages, osteoclasts, endothelial cells, T-lymphocytes, and myeloid-derived immune suppressor cells (MDSCs). CCL2 mediated interactions between normal and malignant cells in the tumor microenvironment and plays a multi-faceted role in tumor progression.

Original languageEnglish (US)
Pages (from-to)41-48
Number of pages8
JournalCytokine and Growth Factor Reviews
Volume21
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

CC Chemokines
Tumors
Prostatic Neoplasms
Carcinogenesis
Neoplasm Metastasis
Ligands
Neoplasms
Tumor Microenvironment
Macrophages
Chemokines
CCR Receptors
CCR2 Receptors
T-cells
Endothelial cells
Osteoclasts
Monocytes
Endothelial Cells
Cells
Inflammation
T-Lymphocytes

Keywords

  • CCL2
  • CCR2
  • Metastasis
  • Prostate cancer
  • Tumorigenesis

ASJC Scopus subject areas

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. / Zhang, Jian; Patel, Lalit; Pienta, Kenneth.

In: Cytokine and Growth Factor Reviews, Vol. 21, No. 1, 02.2010, p. 41-48.

Research output: Contribution to journalArticle

@article{0a00ad7e76ac468fa023aaf95040bcc7,
title = "CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis",
abstract = "CCL2 is a chemokine known to recruit monocytes and macrophages to sites of inflammation. A growing body of research suggests CCL2 is progressively overexpressed in tumor beds and may play a role in the clinical progression of solid tumors. Cancer cells derived from several solid tumor types demonstrate functional receptors for CCL2, suggesting this chemokine may achieve tumorigenicity through direct effects on malignant cells; however, a variety of normal host cells that co-exist with cancer in the tumor microenvironment also respond to CCL2. These cells include macrophages, osteoclasts, endothelial cells, T-lymphocytes, and myeloid-derived immune suppressor cells (MDSCs). CCL2 mediated interactions between normal and malignant cells in the tumor microenvironment and plays a multi-faceted role in tumor progression.",
keywords = "CCL2, CCR2, Metastasis, Prostate cancer, Tumorigenesis",
author = "Jian Zhang and Lalit Patel and Kenneth Pienta",
year = "2010",
month = "2",
doi = "10.1016/j.cytogfr.2009.11.009",
language = "English (US)",
volume = "21",
pages = "41--48",
journal = "Cytokine and Growth Factor Reviews",
issn = "1359-6101",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

AU - Zhang, Jian

AU - Patel, Lalit

AU - Pienta, Kenneth

PY - 2010/2

Y1 - 2010/2

N2 - CCL2 is a chemokine known to recruit monocytes and macrophages to sites of inflammation. A growing body of research suggests CCL2 is progressively overexpressed in tumor beds and may play a role in the clinical progression of solid tumors. Cancer cells derived from several solid tumor types demonstrate functional receptors for CCL2, suggesting this chemokine may achieve tumorigenicity through direct effects on malignant cells; however, a variety of normal host cells that co-exist with cancer in the tumor microenvironment also respond to CCL2. These cells include macrophages, osteoclasts, endothelial cells, T-lymphocytes, and myeloid-derived immune suppressor cells (MDSCs). CCL2 mediated interactions between normal and malignant cells in the tumor microenvironment and plays a multi-faceted role in tumor progression.

AB - CCL2 is a chemokine known to recruit monocytes and macrophages to sites of inflammation. A growing body of research suggests CCL2 is progressively overexpressed in tumor beds and may play a role in the clinical progression of solid tumors. Cancer cells derived from several solid tumor types demonstrate functional receptors for CCL2, suggesting this chemokine may achieve tumorigenicity through direct effects on malignant cells; however, a variety of normal host cells that co-exist with cancer in the tumor microenvironment also respond to CCL2. These cells include macrophages, osteoclasts, endothelial cells, T-lymphocytes, and myeloid-derived immune suppressor cells (MDSCs). CCL2 mediated interactions between normal and malignant cells in the tumor microenvironment and plays a multi-faceted role in tumor progression.

KW - CCL2

KW - CCR2

KW - Metastasis

KW - Prostate cancer

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=77549086214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77549086214&partnerID=8YFLogxK

U2 - 10.1016/j.cytogfr.2009.11.009

DO - 10.1016/j.cytogfr.2009.11.009

M3 - Article

VL - 21

SP - 41

EP - 48

JO - Cytokine and Growth Factor Reviews

JF - Cytokine and Growth Factor Reviews

SN - 1359-6101

IS - 1

ER -